Sinopharm Group Co's EBIT per Share for the
six
months ended in Dec. 2025 was $0.40.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.77.
During the past 12 months, the average EBIT per Share Growth Rate of Sinopharm Group Co was -0.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -9.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -5.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 5.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Sinopharm Group Co's EBIT per Share or its related term are showing as below:
SHTDF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -9.7 Med: 14.9 Max: 59.6
Current: -9.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sinopharm Group Co was 59.60% per year. The lowest was -9.70% per year. And the median was 14.90% per year.
SHTDF's 3-Year EBIT Growth Rate is ranked worse than 80.37% of 107
companies
in the Medical Distribution industry
Industry Median: 4.2
vs SHTDF: -9.20
Sinopharm Group Co (OTCPK:SHTDF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Sinopharm Group Co EBIT per Share Related Terms
Sinopharm Group Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Sinopharm Group Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (SHTDF) has a EBIT per Share of $0.77 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sinopharm Group Co and its competitors. According to the industry distribution chart, Sinopharm Group Co ranks #86 out of 107 companies in the Medical Distribution industry, placing it in the top 80.4%.
Is Sinopharm Group Co's EBIT per Share too high?
Sinopharm Group Co's current EBIT per Share is $0.77. The Medical Distribution industry median EBIT per Share is 4.20. Sinopharm Group Co's value of $0.77 is 81.7% below this industry median. Based on the distribution chart, Sinopharm Group Co ranks #86 out of 107 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sinopharm Group Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's EBIT per Share compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sinopharm Group Co ranks #86 out of 107 companies for EBIT per Share. This places Sinopharm Group Co in the lower half of its industry. The industry median EBIT per Share is 4.20. Sinopharm Group Co's value of $0.77 is 81.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 107 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinopharm Group Co's current EBIT per Share of $0.77 is 81.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sinopharm Group Co and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinopharm Group Co's current EBIT per Share is $0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (SHTDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.78, compared to a current price of $2.29 — trading 17.7% below its estimated fair value. The current EBIT per Share is $0.77 and 81.7% below the Medical Distribution industry median of 4.20. Sinopharm Group Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Sinopharm Group Co (SHTDF), the current EBIT per Share is $0.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Group Co (SHTDF) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued.
The current stock price of $2.29 is trading 17.7% below its estimated GF Value™ of $2.78.
GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.
Key valuation signals for SHTDF:
EBIT per Share: $0.77
GF Value™: $2.78 vs. price of $2.29 (17.7% below fair value)
Industry Position: 81.7% below the Medical Distribution median (#86 of 107)
No single metric tells the full story. See the SHTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
78GF Score
Get the complete analysis for SHTDF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTDF has been successfully added to your 
